DeepBiome Therapeutics is Biotechnology in United States that focus on platform leverages business. Founded in 2016. They cover business area such as developer, infection, central nervous system disorder, deep learning, synthetic biology, technology, drug company.
2016
( 8 years old in 2024 )
Platform Leverages
-
One Kendall Square
Building 200, Suite 001
Cambridge, MA 02139
United States
Private
developerinfectioncentral nervous system disorderdeep learningsynthetic biologytechnologydrug company
* We use standard office opening hours in near DeepBiome Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
DeepBiome Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), DeepBiome Therapeutics business is focusing on Platform Leverages.
DeepBiome Therapeutics headquarter office and corporate office address is located in One Kendall Square Building 200, Suite 001 Cambridge, MA 02139 United States.
DeepBiome Therapeutics was founded in United States.
In 2024, DeepBiome Therapeutics is currently focus on platform leverages sector.
Above is snippet of Google Trends for "platform leverages" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with DeepBiome Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
